Similar articles for PMID: 31240995

Year	Number of Results
2001	3
2002	5
2003	2
2004	4
2005	2
2006	2
2007	1
2008	3
2009	6
2010	3
2011	3
2012	7
2013	4
2014	4
2015	10
2016	10
2017	10
2018	14
2019	7
2020	8
2021	7
2022	6
2023	1
2024	1

1

The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China.

Huang K, Guo Y, Kang J, An L, Zheng Z, Ma L, Peng L, Wang H, Su R, Itoh Y, Wang C. Huang K, et al. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619853500. doi: 10.1177/1753466619853500. Ther Adv Respir Dis. 2019. PMID: 31240995 Free PMC article. Clinical Trial.

2

Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.

Ferguson GT, Tashkin DP, Skärby T, Jorup C, Sandin K, Greenwood M, Pemberton K, Trudo F. Ferguson GT, et al. Respir Med. 2017 Nov;132:31-41. doi: 10.1016/j.rmed.2017.09.002. Epub 2017 Sep 5. Respir Med. 2017. PMID: 29229103 Free article. Clinical Trial.

3

Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia.

Lee SD, Xie CM, Yunus F, Itoh Y, Ling X, Yu WC, Kiatboonsri S. Lee SD, et al. Respirology. 2016 Jan;21(1):119-27. doi: 10.1111/resp.12646. Epub 2015 Sep 23. Respirology. 2016. PMID: 26394882 Clinical Trial.

4

Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.

Fukuchi Y, Samoro R, Fassakhov R, Taniguchi H, Ekelund J, Carlsson LG, Ichinose M. Fukuchi Y, et al. Respirology. 2013 Jul;18(5):866-73. doi: 10.1111/resp.12090. Respirology. 2013. PMID: 23551359 Clinical Trial.

5

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.

Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H. Rennard SI, et al. Int J Chron Obstruct Pulmon Dis. 2016 Aug 17;11:1921-8. doi: 10.2147/COPD.S109661. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27574416 Free PMC article. Clinical Trial.

6

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C. Ichinose M, et al. Int J Chron Obstruct Pulmon Dis. 2019 Dec 23;14:2979-2991. doi: 10.2147/COPD.S220850. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31920295 Free PMC article. Clinical Trial.

7

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease.

Zhong N, Zheng J, Wen F, Yang L, Chen P, Xiu Q, Yao W, Sun T, Zhao Z, Shen H, Shi Y, Lin J, Li Q. Zhong N, et al. Curr Med Res Opin. 2012 Feb;28(2):257-65. doi: 10.1185/03007995.2011.636420. Epub 2012 Jan 20. Curr Med Res Opin. 2012. PMID: 22046961 Clinical Trial.

8

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study.

Ställberg B, Selroos O, Vogelmeier C, Andersson E, Ekström T, Larsson K. Ställberg B, et al. Respir Res. 2009 Feb 19;10(1):11. doi: 10.1186/1465-9921-10-11. Respir Res. 2009. PMID: 19228428 Free PMC article. Clinical Trial.

9

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.

Stynes G, Svedsater H, Wex J, Lettis S, Leather D, Castelnuovo E, Detry M, Berry S. Stynes G, et al. Respir Res. 2015 Feb 15;16(1):25. doi: 10.1186/s12931-015-0184-8. Respir Res. 2015. PMID: 25849223 Free PMC article. Review.

10

Formoterol: a review of its use in chronic obstructive pulmonary disease.

Cheer SM, Scott LJ. Cheer SM, et al. Am J Respir Med. 2002;1(4):285-300. doi: 10.1007/BF03256622. Am J Respir Med. 2002. PMID: 14720051 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year